` 092040 (Amicogen Inc) vs KOSPI 200 Comparison - Alpha Spread

A
092040
vs
K
KOSPI 200

Over the past 12 months, Amicogen Inc has underperformed KOSPI 200, delivering a return of -61% compared to the KOSPI 200's +108% growth.

Stocks Performance
092040 vs KOSPI 200

Loading
092040
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
092040 vs KOSPI 200

Loading
092040
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
092040 vs KOSPI 200

Loading
092040
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Amicogen Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Amicogen Inc
Glance View

Market Cap
96.7B KRW
Industry
Biotechnology

Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. The company is headquartered in Jinju, Gyeongsangnam-Do. The company went IPO on 2013-09-12. The Company’s products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The firm distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.

Intrinsic Value
5 672.94 KRW
Undervaluation 76%
Intrinsic Value
Price
A
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett